Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain.
We report a case with a complete pathology-proven remission after sunitinib treatment of a relapsed irresectable clear cell renal carcinoma. A significant objective response was observed with tumor size reduction during treatment. After surgery, on pathologic examination it was concluded that the patient exhibited a complete response; activity and the feasibility and safety of subsequent surgical resection were assessed. Otherwise after discontinuing sunitinib, the patient had a relapse on the same location; sunitinib has been resumed and was again found to be effective.
Written by:
Vaz MA, Pachón V, Grande E, Ferreiro R, Carrato A. Are you the author?
Reference: Anticancer Drugs. 2011 May 11. Epub ahead of print.
PubMed Abstract
PMID: 21566523
UroToday.com Renal Cancer Section
